DE3380309D1 - Expression vectors for rabies antigenic protein, and their use in the preparation of vaccines - Google Patents

Expression vectors for rabies antigenic protein, and their use in the preparation of vaccines

Info

Publication number
DE3380309D1
DE3380309D1 DE8383400974T DE3380309T DE3380309D1 DE 3380309 D1 DE3380309 D1 DE 3380309D1 DE 8383400974 T DE8383400974 T DE 8383400974T DE 3380309 T DE3380309 T DE 3380309T DE 3380309 D1 DE3380309 D1 DE 3380309D1
Authority
DE
Germany
Prior art keywords
gga
antigenic protein
vaccines
preparation
expression
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
DE8383400974T
Other languages
English (en)
Inventor
Marie-Paule Kieny
Richard Lathe
Jean-Pierre Lecocq
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Transgene SA
Original Assignee
Transgene SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Transgene SA filed Critical Transgene SA
Application granted granted Critical
Publication of DE3380309D1 publication Critical patent/DE3380309D1/de
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/70—Vectors or expression systems specially adapted for E. coli
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/70—Vectors or expression systems specially adapted for E. coli
    • C12N15/73—Expression systems using phage (lambda) regulatory sequences
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/20011—Rhabdoviridae
    • C12N2760/20111—Lyssavirus, e.g. rabies virus
    • C12N2760/20122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
DE8383400974T 1982-05-13 1983-05-13 Expression vectors for rabies antigenic protein, and their use in the preparation of vaccines Expired DE3380309D1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8208401A FR2526661B1 (fr) 1982-05-13 1982-05-13 Nouveaux vecteurs d'expression de la proteine antigenique de la rage et leur application a la preparation de vaccins

Publications (1)

Publication Number Publication Date
DE3380309D1 true DE3380309D1 (en) 1989-09-07

Family

ID=9274023

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8383400974T Expired DE3380309D1 (en) 1982-05-13 1983-05-13 Expression vectors for rabies antigenic protein, and their use in the preparation of vaccines

Country Status (7)

Country Link
EP (1) EP0094887B1 (de)
JP (1) JPS59501293A (de)
AT (1) ATE45183T1 (de)
CA (1) CA1193563A (de)
DE (1) DE3380309D1 (de)
FR (1) FR2526661B1 (de)
WO (1) WO1983004052A1 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1303530C (en) * 1983-01-21 1992-06-16 Michael Courtney EXPRESSION VECTORS AND THEIR USE FOR THE PREPARATION OF A PROTEIN HAVING HUMAN .alpha. -ANTITRYPSIN ACTIVITY
FR2556365B1 (fr) * 1983-12-09 1987-07-31 Transgene Sa Vecteurs de clonage et d'expression de l'interferon-g, bacteries transformees et procede de preparation de l'interferon-g
FR2569420B2 (fr) * 1984-08-27 1988-02-12 Transgene Sa Vecteur d'expression de l'hirudine, procede pour sa preparation par culture de cellules transformees et hirudine obtenue
CA1341414C (fr) * 1984-03-27 2002-12-31 Paul Tolstoshev Vecteurs d'expression de l'hirudine, cellules transformees et procede de preparation de l'hirudine
EP0162738A1 (de) * 1984-04-09 1985-11-27 MOLECULAR GENETICS RESEARCH & DEVELOPMENT LIMITED PARTNERSHIP Herstellung von Untereinheiten von Pseudorabiesvirus-Vakzinen
FR2563434B1 (fr) * 1984-04-25 1986-07-25 Transgene Sa Vaccin contre la rage et procede pour sa preparation
US5830477A (en) * 1984-04-25 1998-11-03 Transgene S.A. Vaccine against rabies and process for preparation thereof
FR2564106B1 (fr) * 1984-05-09 1988-04-22 Transgene Sa Vecteurs d'expression du facteur ix, cellules transformees par ces vecteurs et procede de preparation du facteur ix.
US5169763A (en) * 1986-04-08 1992-12-08 Transgene S.A., Institut Pasteur Viral vector coding glycoprotein of HIV-1
ES2081801T3 (es) * 1987-10-30 1996-03-16 Bristol Myers Squibb Co Plasmidos de expresion.
EP2239330A1 (de) 2009-04-07 2010-10-13 Institut Pasteur Neuronenerzeugung, -erneuerung und -schutz

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2712615A1 (de) * 1977-03-18 1978-09-21 Max Planck Gesellschaft Verfahren zur herstellung von filamentoesen phagen als vektor fuer synthetische rekombinate
BR8101972A (pt) * 1980-06-06 1982-08-17 Biogen Nv Vetor, processo para sua producao, processo para produzir uma molecula recombinante de dna, e processo para produzir um polipeptideo

Also Published As

Publication number Publication date
JPS59501293A (ja) 1984-07-26
FR2526661A1 (fr) 1983-11-18
CA1193563A (fr) 1985-09-17
ATE45183T1 (de) 1989-08-15
FR2526661B1 (fr) 1986-02-21
EP0094887A3 (en) 1984-02-01
WO1983004052A1 (fr) 1983-11-24
EP0094887A2 (de) 1983-11-23
EP0094887B1 (de) 1989-08-02

Similar Documents

Publication Publication Date Title
DE3380309D1 (en) Expression vectors for rabies antigenic protein, and their use in the preparation of vaccines
EP0414263A3 (en) Lactamfree cyclic aminoacids
DE3275837D1 (en) Plasmid, process for its preparation and its use as vector
IT8521472A0 (it) Procedimento per la preparazione di fluoroelastomeri vulcanizzabili e prodotti cosi' ottenuti.
ZA919981B (en) Novel 5-chloroquinolin-8-oxyalkanecarboxylic acid derivatives,processes for their preparation and their use as antidotes for herbicides
FR2686896B1 (fr) Mutant attenue de listeria monocytogenes; souche recombinante de listeria monocytogenes, utilisation comme vecteurs heterologues d'antigenes vaccinal et utilisation comme vaccin ou composition diagnostique.
GB2208116B (en) "thickened canned foodstuffs and methods for their preparation"
IL70414A0 (en) Gene or sub-unit thereof and transfer vector comprising one of them,their preparation and their use for preparing human relaxin
IL60186A (en) Dna transfer vector coding for human pre-growth hormone,microorganisms transformed thereby,method for cloning a deoxynucleotide sequence comprising such a vector,chimeric protein comprising the amino acid sequence of human pre-growth hormone and its preparation
ZA928162B (en) Antibodies in immunosuppression.
GB2208118B (en) "thickened canned foodstuffs and methods for their preparation"
IT9019667A0 (it) Procedimento per la produzione di concentrati di pigmento e prodotti cosi' ottenuti, contraddistinti da alta concentrazione, elevata dispersione e massima resa coloristica
ZA882449B (en) Dihydropyridinamides,a process for their preparation,and their use in medicaments
GB2210617B (en) Tert-butyl derivatives of benzylidenecamphor,process for preparing them,use as antioxidant agents for cosmetic and pharmaceutical compositionscontaining them
DE3662520D1 (en) Cis-1,3,5-triamino 2,4,6-cyclohexanetriol derivatives, their use, process for their preparation and pharmaceutical preparations containing them
FR2556365B1 (fr) Vecteurs de clonage et d'expression de l'interferon-g, bacteries transformees et procede de preparation de l'interferon-g
EP0571771A3 (en) Method of inactivation of viruses in proteinic preparations
HU901384D0 (en) Antidotes comprising substituted 1,8-naphthyridines and process for preparations of the active ingredients
DE3267898D1 (en) Process for the preparation of n,n'-disubstituted 3-amino-propanamides
DE3371270D1 (en) Landing-net system
GB2024223B (en) Process for the preparation of n,n'-disubstituted 2 - naphta - leneethan - imidamides and intermediates used therein
ZA833416B (en) Fluorine-containing 4,6-diamino-s-triazines,processes and new intermediate products for their preparation,and their use as herbicides
IL81293A0 (en) 2,4-diamine-6-haloalkylpyridines,their preparation and their use as herbicides
IL82797A0 (en) 2-phenylacetyl-1,3,5-cyclohexanetriones,their preparation and their use as herbicides
EP0188007A3 (en) Process for the preparation of 2-nitro-3-aminopyridine, and of n,n'-di-(2-nitro-pyridyl) urea occurring as an intermediate product

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee